| Literature DB >> 34523743 |
Maximilian M Delsmann1,2, Richard Seist3,4, Julian Stürznickel1,2, Felix N Schmidt1, Amer Mansour3, Margaret M Kobelski5, Gabriel Broocks6, Jonathan Peichl7, Ralf Oheim1, Mark Praetorius7, Thorsten Schinke1, Michael Amling1, Marie B Demay5, Konstantina M Stankovic3,4, Tim Rolvien2.
Abstract
X-linked hypophosphatemia (XLH) is a hereditary musculoskeletal disorder caused by loss-of-function mutations in the PHEX gene. In XLH, increased circulating fibroblast growth factor 23 (FGF23) levels cause renal phosphate wasting and low concentrations of 1,25-dihydroxyvitamin D, leading to an early clinical manifestation of rickets. Importantly, hearing loss is commonly observed in XLH patients. We present here data from two XLH patients with marked conductive hearing loss. To decipher the underlying pathophysiology of hearing loss in XLH, we utilized the Hyp mouse model of XLH and measured auditory brain stem responses (ABRs) and distortion product otoacoustic emissions (DPOAEs) to functionally assess hearing. As evidenced by the increased ABR/DPOAE threshold shifts in the mid-frequency range, these measurements indicated a predominantly conductive hearing loss in Hyp mice compared to wild-type (WT) mice. Therefore, we carried out an in-depth histomorphometric and scanning electron microscopic analysis of the auditory ossicles. Quantitative backscattered electron imaging (qBEI) indicated a severe hypomineralization of the ossicles in Hyp mice, evidenced by lower calcium content (CaMean) and higher void volume (ie, porosity) compared to WT mice. Histologically, voids correlated with unmineralized bone (ie, osteoid), and the osteoid volume per bone volume (OV/BV) was markedly higher in Hyp mice than WT mice. The density of osteocyte lacunae was lower in Hyp mice than in WT mice, whereas osteocyte lacunae were enlarged. Taken together, our findings highlight the importance of ossicular mineralization for hearing conduction and point toward the potential benefit of improving mineralization to prevent hearing loss in XLH.Entities:
Keywords: ANIMAL MODELS; BONE MATRIX; CELL/TISSUE SIGNALING - ENDOCRINE PATHWAYS; GENETIC ANIMAL MODELS; MATRIX MINERALIZATION; PTH/Vit D/FGF23
Mesh:
Substances:
Year: 2021 PMID: 34523743 PMCID: PMC8688200 DOI: 10.1002/jbmr.4443
Source DB: PubMed Journal: J Bone Miner Res ISSN: 0884-0431 Impact factor: 6.741